Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?

Objectives: The current study evaluated the long‑term lung abnormalities based on initial and follow‑up chest computed tomography (CT) images of COVID‑19 patients and investigates the possible factors associated with them. Methods: One hundred and twenty‑four hospitalized COVID‑19 patients who recei...

Full description

Bibliographic Details
Main Authors: Bahareh Safikhani, Soheil Rahmani Fard, Leyla Bahadorizadeh, Fatemeh Shakki Katouli, Yousef Alimohamadi, Sara Minaeian
Format: Article
Language:English
Published: Kashan University of Medical Sciences 2023-07-01
Series:International Archives of Health Sciences
Subjects:
Online Access:http://iahsj.kaums.ac.ir/article_176536_5661cb3311046a587b3c3e3d3f6732f4.pdf
_version_ 1797680957063430144
author Bahareh Safikhani
Soheil Rahmani Fard
Leyla Bahadorizadeh
Fatemeh Shakki Katouli
Yousef Alimohamadi
Sara Minaeian
author_facet Bahareh Safikhani
Soheil Rahmani Fard
Leyla Bahadorizadeh
Fatemeh Shakki Katouli
Yousef Alimohamadi
Sara Minaeian
author_sort Bahareh Safikhani
collection DOAJ
description Objectives: The current study evaluated the long‑term lung abnormalities based on initial and follow‑up chest computed tomography (CT) images of COVID‑19 patients and investigates the possible factors associated with them. Methods: One hundred and twenty‑four hospitalized COVID‑19 patients who received a follow‑up chest CT scan in three hospitals in Tehran between February 20, 2021 and September, 2021, were included. Based on the presence of persistent lesions in the follow‑up images, patients were divided into residual and nonresidual groups, and logistic regression analysis was performed to investigate the association between different disease characteristics and long‑term lung abnormalities. Results: The most frequent abnormality in the initial imaging was ground‑glass opacities which was observed in 95.3% of patients, and residual lesions were observed in 39.8% of patients at the follow‑up date. Patients in the residual group were generally older, more frequently suffered from hypertension and dyspnea, and had lower oxygen saturation and lymphocyte count, and lymphopenia was more prevalent among them. Moreover, patients in the residual group had higher initial lung involvement score, and the presence of lymphadenopathy and consolidation was more frequent among them. After adjustment for age, gender, and intervals between the two imagings, logistic regression results showed that hospitalization period, dyspnea, decreased oxygen saturation, decreased lymphocyte count, lymphopenia, consolidation, lymphadenopathy, and high initial lung involvement were strongly associated with the presence of long‑term abnormalities. Conclusion: The current study revealed multiple discrepancies between residual and nonresidual groups, which can be used to better identify the patients at risk of long‑term COVID‑19 lung complications.
first_indexed 2024-03-11T23:38:21Z
format Article
id doaj.art-bd31c96b6aa64b9488f9e9bf6ef7e481
institution Directory Open Access Journal
issn 2383-2568
language English
last_indexed 2024-03-11T23:38:21Z
publishDate 2023-07-01
publisher Kashan University of Medical Sciences
record_format Article
series International Archives of Health Sciences
spelling doaj.art-bd31c96b6aa64b9488f9e9bf6ef7e4812023-09-19T17:49:26ZengKashan University of Medical SciencesInternational Archives of Health Sciences2383-25682023-07-01102475210.48307/iahsj.2023.176536176536Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?Bahareh Safikhani0Soheil Rahmani Fard1Leyla Bahadorizadeh2Fatemeh Shakki Katouli3Yousef Alimohamadi4Sara Minaeian5Department of Radiology, Rasool-E-Akram General Hospital, Iran University of Medical sciences, Tehran, IranAntimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, IranAntimicrobial Resistance Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran Department of Internal Medicine, Rasool-E-Akram General Hospital, Iran University of Medical Sciences, Tehran, IranDepartment of Radiology, Arash Women General Hospital, Tehran University of Medical Sciences, Tehran, IranPars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, IranPars Advanced and Minimally Invasive Medical Manners Research Center, Pars Hospital, Iran University of Medical Sciences, Tehran, IranObjectives: The current study evaluated the long‑term lung abnormalities based on initial and follow‑up chest computed tomography (CT) images of COVID‑19 patients and investigates the possible factors associated with them. Methods: One hundred and twenty‑four hospitalized COVID‑19 patients who received a follow‑up chest CT scan in three hospitals in Tehran between February 20, 2021 and September, 2021, were included. Based on the presence of persistent lesions in the follow‑up images, patients were divided into residual and nonresidual groups, and logistic regression analysis was performed to investigate the association between different disease characteristics and long‑term lung abnormalities. Results: The most frequent abnormality in the initial imaging was ground‑glass opacities which was observed in 95.3% of patients, and residual lesions were observed in 39.8% of patients at the follow‑up date. Patients in the residual group were generally older, more frequently suffered from hypertension and dyspnea, and had lower oxygen saturation and lymphocyte count, and lymphopenia was more prevalent among them. Moreover, patients in the residual group had higher initial lung involvement score, and the presence of lymphadenopathy and consolidation was more frequent among them. After adjustment for age, gender, and intervals between the two imagings, logistic regression results showed that hospitalization period, dyspnea, decreased oxygen saturation, decreased lymphocyte count, lymphopenia, consolidation, lymphadenopathy, and high initial lung involvement were strongly associated with the presence of long‑term abnormalities. Conclusion: The current study revealed multiple discrepancies between residual and nonresidual groups, which can be used to better identify the patients at risk of long‑term COVID‑19 lung complications.http://iahsj.kaums.ac.ir/article_176536_5661cb3311046a587b3c3e3d3f6732f4.pdfcovid-19computed tomographyfollow-up
spellingShingle Bahareh Safikhani
Soheil Rahmani Fard
Leyla Bahadorizadeh
Fatemeh Shakki Katouli
Yousef Alimohamadi
Sara Minaeian
Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?
International Archives of Health Sciences
covid-19
computed tomography
follow-up
title Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?
title_full Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?
title_fullStr Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?
title_full_unstemmed Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?
title_short Post-COVID-19 chest imaging evaluation: which patients should be prioritized for follow-up pulmonary assessment?
title_sort post covid 19 chest imaging evaluation which patients should be prioritized for follow up pulmonary assessment
topic covid-19
computed tomography
follow-up
url http://iahsj.kaums.ac.ir/article_176536_5661cb3311046a587b3c3e3d3f6732f4.pdf
work_keys_str_mv AT baharehsafikhani postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment
AT soheilrahmanifard postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment
AT leylabahadorizadeh postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment
AT fatemehshakkikatouli postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment
AT yousefalimohamadi postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment
AT saraminaeian postcovid19chestimagingevaluationwhichpatientsshouldbeprioritizedforfollowuppulmonaryassessment